Anaerobic microbes in the human gut produce beneficial and harmful compounds, as well as neutral compounds like trimethylamine, which undergoes microbial metabolism or host-catalyzed transformation into proatherogenic trimethylamine-N-oxide. Ellenbogen et al. identified a microbiome-associated demethylase that short-circuits the production of trimethylamine-N-oxide from the metabolite γ-butyrobetaine and instead produces methyltetrahydrofolate, a key intermediate in the microbial production of beneficial small-chain fatty acids. This article highlights an example of how the microbiome is integrally involved in producing metabolites that support our health and in preventing the formation of compounds that promote disease.
Keywords: Eubacterium limosum; Wood–Ljungdahl pathway; demethylase; methyltransferase; microbiome; short chain fatty acid; trimethylamine; trimethylamine-N-oxide; vitamin B(12); γ-butyrobetaine.
Copyright © 2021 The Author. Published by Elsevier Inc. All rights reserved.